NASDAQ: SGRY Surgery Partners, Inc. 8-K

Surgery Partners holds routine annual meeting, re-elects directors through 2029

Filed June 5, 2026 · Period ending June 5, 2026 · ~1 min read

Key Changes

  • low

    Shareholders re-elected three Class II directors (Devin O'Reilly, Brent Turner, and Laura L. Forese, M.D.) to serve until the 2029 annual meeting. All three were incumbents standing for re-election.

  • low

    Executive compensation approved on advisory basis with 111.6 million votes for versus 2.0 million against. This non-binding say-on-pay vote is a routine regulatory requirement.

  • low

    Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 119.8 million votes in favor, confirming the audit committee's selection.

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade SGRY commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 8, 2026 4:16 AM